CSPC Pharmaceutical Group (FRA:CVGU) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:CVGU CSPC Pharmaceutical Group Ltd FRA:CVGU
83 GF Score
Price €3.42
GF Value €2.65
! 4 Warning Signs
View Full Analysis

What is CSPC Pharmaceutical Group FFO per Share?

FFO per Share only applies to REITs.

FRA:CVGU
83GF Score
CSPC Pharmaceutical Group Ltd FRA:CVGU
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is CSPC Pharmaceutical Group (FRA:CVGU) Overvalued in 2026?

Based on GuruFocus' analysis, CSPC Pharmaceutical Group stock appears to be overvalued. The current stock price of €3.42 is trading 29.1% above its estimated GF Value™ of €2.65.

Key valuation signals for FRA:CVGU:

  • FFO per Share:
  • GF Value™: €2.65 vs. price of €3.42 (29.1% above fair value)
  • GF Score™: 83/100 with 4 warning signs

No single metric tells the full story. See the FRA:CVGU stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CSPC Pharmaceutical Group Business Description

Address No.896 Zhongshandong Street, Gaoxin District, Hebei Province, Shijiazhuang, CHN, 050035
CSPC Pharmaceutical Group LTD is engaged in the manufacture and sale of pharmaceutical products. The group's segments include: Finished drugs, consisting research and development, manufacture and sale of pharmaceutical products and license fee income; Bulk products, that manufacture and sale of vitamin C, and antibiotic products in bulk powder form; and Functional food and others, that manufacture and sale of functional food products (including caffeine food additives, anhydrous glucose, acarbose and vitamin C buccal tablets), provision of healthcare service and others. It derives maximum revenue from Finished Products segments. Geographically, the company operates in Chinese Mainland, which Chinese Mainland generates maximum revenue; Other Asian regions; Europe; North America; and Others.
83GF Score

Get the complete analysis for FRA:CVGU

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.42
Price
€2.65
GF Value